Related Experiment Video
Updated: Jul 12, 2025
06:16
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
441
Should additional value elements be included in cost-effectiveness analysis in pharmacoeconomic evaluation: a novel
Lihua Sun1, Shiqi Li2, Xiaochen Peng2,3
1School of Business Administration, Shenyang Pharmaceutical University, Shenyang, Liaoning, China. slh-3632@163.com.
Cost Effectiveness and Resource Allocation : C/E
|October 29, 2023
Summary
Incorporating additional value elements into cost-effectiveness analysis (CEA) is deemed unscientific. Pharmacoeconomic evaluations should remain within their essential scope, excluding factors beyond core cost-effectiveness.
Area of Science:
- Health Economics
- Pharmacoeconomics
- Decision Science
Background:
- Quality-adjusted life-years (QALYs) may not fully capture intervention benefits.
- Academics propose adding 'value flower' elements (e.g., hope, option value) to cost-effectiveness analysis (CEA).
Discussion:
- This paper examines the scope and scientific validity of expanding CEA.
- It traces the origins and core concepts of pharmacoeconomic evaluation.
- The analysis argues against incorporating additional value elements into CEA.
Key Insights:
- Expanding CEA beyond its core function is considered unscientific and unreasonable.
- Current pharmacoeconomic evaluation capabilities do not encompass these additional value elements.
- The study concludes that such expansions exceed the essential scope of the field.
Outlook:
- The findings are theoretical and require empirical validation.
- Future research should focus on verifying the scientificity and reasonableness of these conclusions.
- Further investigation is needed to define the precise boundaries of pharmacoeconomic evaluation.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
133
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
133
01:12Analysis of Population Pharmacokinetic Data
267
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
267
01:22Dose-Response Relationship: Potency and Efficacy
4.5K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.5K
01:26Pharmacokinetic Models: Comparison and Selection Criterion
79
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
79
00:54Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
106
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
106
01:16Bioequivalence: Overview
1.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.1K